查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930060

全球软胶囊市场：市场规模、占有率、成长率、产业分析、按类型、应用和地区划分的考量、未来预测（2025-2034）

Softgel Capsules Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 216 Pages | 商品交期: 请询问到货日

价格

软胶囊市场成长因素

预计2025年全球软胶囊市场规模将达78.7亿美元，2026年将达83.2亿美元。预计2034年，市场规模将最终成长至134.4亿美元，预测期内复合年增长率（CAGR）为6.18%。北美将在2025年以35.60%的市占率引领市场，主要得益于临床试验的增加、强大的研发基础设施以及主要製药厂商的强大影响力。预计到2032年，美国市场规模将达到39.2亿美元，主要得益于越来越多的临床研究推动软胶囊在慢性疾病治疗的应用。市场上的主要参与者包括 Capsules (Lonza)、Catalent、Sirio Pharma 和 Aenova Holdings，它们都专注于产品创新和市场扩张。

软胶囊是一种口服剂型，其核心为半固体或液体，外层包裹着明胶、遮光剂和增塑剂，如山梨糖醇和甘油。这些胶囊具有更高的生物可利用性、稳定性和溶解度，使其适用于药品、营养保健品和膳食补充剂。预防医学意识的提高、心血管疾病等慢性病盛行率的上升以及人口老化是推动全球软胶囊市场发展的关键因素。

市场驱动因素

临床试验和产品上市数量的增加：越来越多的临床研究评估软胶囊在治疗慢性病方面的疗效，这是推动市场成长的主要因素。例如，2021年8月，InnoPharmax公司进行了一项试验，评估一种用于治疗胆道癌的软胶囊组合製剂。主要公司的产品创新，例如Catalent公司的OptiGel DR技术（可实现缓释和肠溶胶囊），也正在推动市场扩张。

植物性胶囊的需求：素食和纯素软胶囊因其天然、不含动物成分、不含麸质、非基因改造且溶解性更佳而日益受到欢迎。消费者认为它们更安全、更有效，尤其是在欧洲、北美和亚太地区，这为新产品线和市场差异化创造了机会。

保健和营养补充剂市场成长：受维生素和补充剂在预防慢性疾病（包括心血管疾病和与年龄相关的健康问题）方面需求不断增长的推动，保健和营养补充剂细分市场预计将在2026年占57.23%的市场占有率。此外，由于慢性病盛行率的上升以及仿製药和创新製剂获得监管部门批准，处方软胶囊製剂正经历显着增长。

市场限制因子

专利到期和仿製药竞争：关键药物专利保护期的结束会对製药公司的收入产生负面影响，导致仿製药竞争。这会影响市场动态，也可能影响专利软胶囊产品的成长潜力。

市场区隔

依类型划分：市场分为明胶胶囊和非动物源性软胶囊。 2026年，明胶胶囊占了最大的市场占有率，达到85.21%，这主要得益于强劲的研发投入、高产能和成熟的生产流程。非动物性软胶囊（包括纤维素胶囊和普鲁兰胶囊）由于对纯素食产品的需求不断增长，正经历稳定增长。

按生产商划分：製药公司在2026年占了57.04%的市场占有率，这主要得益于其大规模生产和大量的研发投入。膳食补充剂生产商也做出了显着贡献，这主要得益于全球范围内新推出的膳食补充剂产品数量的不断增长。

依地区划分：

  • 北美：预计2025年市场规模将达到28亿美元，2026年将达到29.7亿美元，主要得益于活跃的临床试验活动和FDA批准的产品上市。
  • 亚太地区：由于患者群体庞大且製药公司众多，预计该市场在预测期内将实现最高的复合年增长率。预计到2026年，中国市场规模将达到6.4亿美元，日本将达到4.4亿美元，印度将达到2.5亿美元。
  • 欧洲：对明胶胶囊研发的投资以及素食软胶囊技术的创新预计将推动强劲成长。 预计到 2026 年，德国的市场规模将达到 6.3 亿美元，英国将达到 4 亿美元。
  • 中东、非洲和拉丁美洲：由于慢性病盛行率上升以及膳食补充剂使用率不断提高，预计这些地区具有很高的成长潜力。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要公司新产品发布
  • 主要国家和地区的监管概况
  • 关键产业趋势：併购、业务合作
  • 新冠疫情对市场的影响

第五章 全球软胶囊市场分析：洞察与预测 （2021-2034）

  • 市场分析、洞察与预测：依类型划分
    • 明胶胶囊
    • 非动物性软胶囊
      • 淀粉
      • 普鲁兰
      • 其他
  • 市场分析、洞察与预测：依应用划分
    • 处方药
    • 保健品与膳食补充剂
  • 市场分析、洞察与预测：依製造商划分
    • 製药公司
    • 营养保健品公司
    • 其他
  • 市场分析、洞察与预测：按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东及非洲

第六章 北美软胶囊市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲软胶囊市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲国家

第八章 亚太地区软胶囊市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 印度
    • 中国
    • 日本
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲软胶囊市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲软胶囊市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会国家
    • 南非
    • 中东和非洲其他地区

第十一章 竞争格局分析

  • 全球市占率分析（2025）
  • 公司简介
    • Capsugel（龙沙）
    • Sirio Pharma Co., Ltd.
    • Catalent, Inc.
    • Aenova Holding GmbH
    • Fuji Capsule Co., Ltd.
    • CAPTEK Softgel International Inc.
    • Curtis Health Caps
    • EuroCaps Ltd
Product Code: FBI103353

Growth Factors of softgel capsules Market

The global softgel capsules market was valued at USD 7.87 billion in 2025 and is projected to reach USD 8.32 billion in 2026, ultimately expanding to USD 13.44 billion by 2034, reflecting a CAGR of 6.18% during the forecast period. North America dominated the market in 2025 with a 35.60% share, driven by rising clinical trials, strong R&D infrastructure, and a high presence of key pharmaceutical manufacturers. The U.S. market is projected to reach USD 3.92 billion by 2032, supported by the growing number of clinical studies promoting the usage of softgel capsules for chronic ailments. Key players include Capsugel (Lonza), Catalent, Inc., Sirio Pharma, and Aenova Holding GmbH, focusing on product innovation and market expansion.

Softgel capsules are oral dosage forms containing a semi-solid or liquid core encapsulated within gelatin, opacifiers, and plasticizers such as sorbitol or glycerin. These capsules offer enhanced bioavailability, stability, and solubility, making them suitable for pharmaceuticals, nutraceuticals, and dietary supplements. Increasing awareness of preventive healthcare, rising prevalence of chronic diseases such as cardiovascular disorders, and a growing geriatric population are major factors driving the global softgel capsules market.

Market Drivers

Rising Clinical Trials and Product Launches: The increasing number of clinical studies evaluating softgel capsules for treating chronic diseases is a key growth driver. For example, in August 2021, InnoPharmax Inc. sponsored trials to assess softgel combinations for biliary tract cancer treatment. Product innovations by key players such as Catalent's OptiGel DR technology, enabling delayed or enteric-release capsules, further support market expansion.

Demand for Plant-Based Capsules: Vegetarian or vegan softgel capsules are gaining popularity due to their natural, non-animal composition, absence of gluten, GMO-free status, and improved solubility. These capsules are viewed as safer and more effective by consumers, particularly in Europe, North America, and Asia Pacific, creating opportunities for new product lines and market differentiation.

Health & Dietary Supplements Growth: In 2026, the health & dietary supplements segment accounted for 57.23% share, driven by the growing need for vitamins and supplements to prevent chronic diseases, including cardiovascular conditions and age-related health issues. Prescription medicines in softgel form are also witnessing significant growth, supported by chronic disease prevalence and regulatory approvals for generic and innovative formulations.

Market Restraints

Patent Expirations and Generic Competition: Loss of patent exclusivity for leading drugs may negatively impact pharmaceutical companies' revenues, introducing generic competition. This could influence market dynamics and affect growth potential for proprietary softgel products.

Market Segmentation

By Type: The market is segmented into gelatin capsules and non-animal softgel capsules. In 2026, gelatin capsules held the largest market share at 85.21%, driven by robust R&D investments, high production capacity, and established manufacturing processes. The non-animal segment, including cellulose-based and pullulan capsules, is growing steadily due to rising demand for vegan-friendly options.

By Manufacturer: Pharmaceutical companies dominate with 57.04% share in 2026, supported by large-scale production and extensive R&D investments. Nutraceutical companies also contribute significantly, benefiting from the global rise in dietary supplement launches.

By Region:

  • North America: Dominated with USD 2.8 billion in 2025 and projected USD 2.97 billion in 2026, driven by strong clinical trial activity and FDA-approved product launches.
  • Asia Pacific: Expected to record the highest CAGR during the forecast period due to a large patient pool and expansion of pharmaceutical companies. In 2026, China USD 0.64 billion, Japan USD 0.44 billion, and India USD 0.25 billion.
  • Europe: Strong growth due to investments in gelatin capsule research and innovations in vegan softgel technologies. Germany USD 0.63 billion, UK USD 0.4 billion in 2026.
  • Middle East & Africa and Latin America: High growth potential driven by rising chronic disease prevalence and increasing dietary supplement adoption.

Competitive Landscape

The global market is moderately consolidated, with Capsugel (Lonza) and Catalent, Inc. leading in revenue and product innovation. Key industry developments include the launch of Amneal Pharmaceuticals' Icosapent ethyl softgel in December 2023 and Roquette's LYCAGEL PREMIX in November 2021. Companies are focusing on expanding geographic presence, pipeline development, and advanced manufacturing technologies.

Conclusion

The global softgel capsules market is expected to grow from USD 7.87 billion in 2025 to USD 13.44 billion by 2034, driven by rising clinical trials, growing chronic disease prevalence, demand for plant-based capsules, and increasing adoption of dietary supplements. North America leads the market, while Asia Pacific is poised for the fastest growth. Gelatin capsules dominate, supported by R&D and manufacturing capacities, whereas non-animal capsules are gaining traction due to consumer preference. The market outlook remains strong as key players focus on innovation, regulatory approvals, and global expansion, ensuring sustained growth and enhanced product availability worldwide.

Segmentation By Type

  • Gelatin Capsules
  • Non-animal Softgel Capsules
    • Starches
    • Pullulan
    • Others

By Application

  • Prescription Medicines
  • Health & Dietary Supplements

By Manufacturers

  • Pharmaceutical Companies
  • Nutraceutical Companies
  • Others

By Region

  • North America (By Type, By Application, By Manufacturers, and By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Application, By Manufacturers, and By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By Manufacturers, and By Country/Sub-Region)
    • India
    • China
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, By Application, By Manufacturers, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Application, By Manufacturers, and By Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. New Product Launch, By Key Players
  • 4.2. Overview of Regulatory Scenario, By Key Countries/ Regions
  • 4.3. Key Industry Developments-Mergers, Acquisitions, and Partnerships
  • 4.4. Impact of Covid-19 on the Market

5. Global Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Gelatin Capsules
    • 5.1.2. Non-animal Softgel Capsules
      • 5.1.2.1. Starches
      • 5.1.2.2. Pullulan
      • 5.1.2.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Prescription Medicines
    • 5.2.2. Health & Dietary Supplements
  • 5.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 5.3.1. Pharmaceutical Companies
    • 5.3.2. Nutraceutical Companies
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Gelatin Capsules
    • 6.1.2. Non-animal Softgel Capsules
      • 6.1.2.1. Starches
      • 6.1.2.2. Pullulan
      • 6.1.2.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Prescription Medicines
    • 6.2.2. Health & Dietary Supplements
  • 6.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 6.3.1. Pharmaceutical Companies
    • 6.3.2. Nutraceutical Companies
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Gelatin Capsules
    • 7.1.2. Non-animal Softgel Capsules
      • 7.1.2.1. Starches
      • 7.1.2.2. Pullulan
      • 7.1.2.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Prescription Medicines
    • 7.2.2. Health & Dietary Supplements
  • 7.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 7.3.1. Pharmaceutical Companies
    • 7.3.2. Nutraceutical Companies
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Gelatin Capsules
    • 8.1.2. Non-animal Softgel Capsules
      • 8.1.2.1. Starches
      • 8.1.2.2. Pullulan
      • 8.1.2.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Prescription Medicines
    • 8.2.2. Health & Dietary Supplements
  • 8.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 8.3.1. Pharmaceutical Companies
    • 8.3.2. Nutraceutical Companies
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. India
    • 8.4.2. China
    • 8.4.3. Japan
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Gelatin Capsules
    • 9.1.2. Non-animal Softgel Capsules
      • 9.1.2.1. Starches
      • 9.1.2.2. Pullulan
      • 9.1.2.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Prescription Medicines
    • 9.2.2. Health & Dietary Supplements
  • 9.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 9.3.1. Pharmaceutical Companies
    • 9.3.2. Nutraceutical Companies
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Softgel Capsules Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Gelatin Capsules
    • 10.1.2. Non-animal Softgel Capsules
      • 10.1.2.1. Starches
      • 10.1.2.2. Pullulan
      • 10.1.2.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Prescription Medicines
    • 10.2.2. Health & Dietary Supplements
  • 10.3. Market Analysis, Insights and Forecast - By Manufacturers
    • 10.3.1. Pharmaceutical Companies
    • 10.3.2. Nutraceutical Companies
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC Countries
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Capsugel (Lonza)
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. financials (Based on Availability)
    • 11.2.2. Sirio Pharma Co., Ltd.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. financials (Based on Availability)
    • 11.2.3. Catalent, Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. financials (Based on Availability)
    • 11.2.4. Aenova Holding GmbH
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. financials (Based on Availability)
    • 11.2.5. Fuji Capsule Co., Ltd.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. financials (Based on Availability)
    • 11.2.6. CAPTEK Softgel International Inc.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. financials (Based on Availability)
    • 11.2.7. Curtis Health Caps
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. financials (Based on Availability)
    • 11.2.8. EuroCaps Ltd
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. financials (Based on Availability)

List of Tables

  • Table 1: Global Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 2: Global Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 3: Global Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 4: Global Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 5: Global Softgel Capsules Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 6: North America Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 7: North America Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 8: North America Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 9: North America Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 10: North America Softgel Capsules Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 12: Europe Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 13: Europe Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 14: Europe Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 15: Europe Softgel Capsules Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 16: Asia Pacific Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 17: Asia Pacific Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 18: Asia Pacific Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Asia Pacific Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 20: Asia Pacific Softgel Capsules Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 21: Latin America Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 22: Latin America Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 23: Latin America Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Latin America Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 25: Latin America Softgel Capsules Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 26: Middle East & Africa Softgel Capsules Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 27: Middle East & Africa Softgel Capsules Market Revenue (USD billion) Forecast, By Non-animal Softgel Capsules, 2021-2034
  • Table 28: Middle East & Africa Softgel Capsules Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 29: Middle East & Africa Softgel Capsules Market Revenue (USD billion) Forecast, By Manufacturers, 2021-2034
  • Table 30: Middle East & Africa Softgel Capsules Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Softgel Capsules Market Revenue Breakdown (USD billion, %) By Region, 2025 & 2034
  • Figure 2: Global Softgel Capsules Market Value Share (%), By Type, 2025 & 2034
  • Figure 3: Global Softgel Capsules Market Value Share (%), By Application, 2025 & 2034
  • Figure 4: Global Softgel Capsules Market Value Share (%), By Manufacturers, 2025 & 2034
  • Figure 5: Global Softgel Capsules Market Value (USD billion), By Region, 2025 & 2034
  • Figure 6: North America Softgel Capsules Market Value (USD billion), By Type, 2025 & 2034
  • Figure 7: North America Softgel Capsules Market Value Share (%), By Type, 2025
  • Figure 8: North America Softgel Capsules Market Value (USD billion), By Application, 2025 & 2034
  • Figure 9: North America Softgel Capsules Market Value Share (%), By Application, 2025
  • Figure 10: North America Softgel Capsules Market Value (USD billion), By Manufacturers, 2025 & 2034
  • Figure 11: North America Softgel Capsules Market Value Share (%), By Manufacturers, 2025
  • Figure 12: North America Softgel Capsules Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Softgel Capsules Market Value Share (%), By Country, 2025
  • Figure 14: Europe Softgel Capsules Market Value (USD billion), By Type, 2025 & 2034
  • Figure 15: Europe Softgel Capsules Market Value Share (%), By Type, 2025
  • Figure 16: Europe Softgel Capsules Market Value (USD billion), By Application, 2025 & 2034
  • Figure 17: Europe Softgel Capsules Market Value Share (%), By Application, 2025
  • Figure 18: Europe Softgel Capsules Market Value (USD billion), By Manufacturers, 2025 & 2034
  • Figure 19: Europe Softgel Capsules Market Value Share (%), By Manufacturers, 2025
  • Figure 20: Europe Softgel Capsules Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 21: Europe Softgel Capsules Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 22: Asia Pacific Softgel Capsules Market Value (USD billion), By Type, 2025 & 2034
  • Figure 23: Asia Pacific Softgel Capsules Market Value Share (%), By Type, 2025
  • Figure 24: Asia Pacific Softgel Capsules Market Value (USD billion), By Application, 2025 & 2034
  • Figure 25: Asia Pacific Softgel Capsules Market Value Share (%), By Application, 2025
  • Figure 26: Asia Pacific Softgel Capsules Market Value (USD billion), By Manufacturers, 2025 & 2034
  • Figure 27: Asia Pacific Softgel Capsules Market Value Share (%), By Manufacturers, 2025
  • Figure 28: Asia Pacific Softgel Capsules Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific Softgel Capsules Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 30: Latin America Softgel Capsules Market Value (USD billion), By Type, 2025 & 2034
  • Figure 31: Latin America Softgel Capsules Market Value Share (%), By Type, 2025
  • Figure 32: Latin America Softgel Capsules Market Value (USD billion), By Application, 2025 & 2034
  • Figure 33: Latin America Softgel Capsules Market Value Share (%), By Application, 2025
  • Figure 34: Latin America Softgel Capsules Market Value (USD billion), By Manufacturers, 2025 & 2034
  • Figure 35: Latin America Softgel Capsules Market Value Share (%), By Manufacturers, 2025
  • Figure 36: Latin America Softgel Capsules Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 37: Latin America Softgel Capsules Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 38: Middle East & Africa Softgel Capsules Market Value (USD billion), By Type, 2025 & 2034
  • Figure 39: Middle East & Africa Softgel Capsules Market Value Share (%), By Type, 2025
  • Figure 40: Middle East & Africa Softgel Capsules Market Value (USD billion), By Application, 2025 & 2034
  • Figure 41: Middle East & Africa Softgel Capsules Market Value Share (%), By Application, 2025
  • Figure 42: Middle East & Africa Softgel Capsules Market Value (USD billion), By Manufacturers, 2025 & 2034
  • Figure 43: Middle East & Africa Softgel Capsules Market Value Share (%), By Manufacturers, 2025
  • Figure 44: Middle East & Africa Softgel Capsules Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 45: Middle East & Africa Softgel Capsules Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 46: Global Softgel Capsules Market Share (%), By Company, 2025